Showing results (1-10 of 355) with videos related to
Sort By:
Pageof 36
Journal of Medicinal Chemistry|January 31, 2013
Development of κ opioid receptor antagonistsF Ivy Carroll, William A CarlezonBiological Psychiatry|August 1, 2015
Pituitary Adenylate Cyclase-Activating Polypeptide Disrupts Motivation, Social Interaction, and Attention in Male Sprague Dawley RatsRachel J Donahue, Archana Venkataraman, F Ivy Carroll, et al.The Journal of Pharmacology and Experimental Therapeutics|September 8, 2007
Anxiolytic-like effects of kappa-opioid receptor antagonists in models of unlearned and learned fear in ratsAllison T Knoll, Edward G Meloni, James B Thomas, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 6, 2012
Corticotropin-releasing factor (CRF)-induced disruption of attention in rats is blocked by the κ-opioid receptor antagonist JDTicAshlee Van't Veer, Jessica M Yano, F Ivy Carroll, et al.Behavioural Pharmacology|June 26, 2015
Effects of acute and chronic social defeat stress are differentially mediated by the dynorphin/kappa-opioid receptor systemRachel J Donahue, Samantha M Landino, Sam A Golden, et al.Pharmacology, Biochemistry, and Behavior|November 26, 2021
Blockade of kappa-opioid receptors amplifies microglia-mediated inflammatory responsesGalen Missig, Emma L Fritsch, Niyati Mehta, et al.BMC Pharmacology|May 31, 2012
Long-acting κ opioid antagonists nor-BNI, GNTI and JDTic: pharmacokinetics in mice and lipophilicityThomas A Munro, Loren M Berry, Ashlee Van't Veer, et al.The International Journal of Neuropsychopharmacology|October 16, 2019
Behavioral Pharmacology of Novel Kappa Opioid Receptor Antagonists in RatsSarah Page, Maria M Mavrikaki, Tania Lintz, et al.Psychopharmacology|April 2, 2010
Role of kappa-opioid receptors in the effects of salvinorin A and ketamine on attention in ratsChristina L Nemeth, Tracie A Paine, Joseph E Rittiner, et al.Annals of the New York Academy of Sciences|November 11, 2008
Antagonists at metabotropic glutamate receptor subtype 5: structure activity relationships and therapeutic potential for addictionF Ivy CarrollPageof 36